These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3925406)

  • 1. Pseudomonas aeruginosa in the oral cavity and sputum of patients with cystic fibrosis.
    Komiyama K; Tynan JJ; Habbick BF; Duncan DE; Liepert DJ
    Oral Surg Oral Med Oral Pathol; 1985 Jun; 59(6):590-4. PubMed ID: 3925406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization by pyocine typing and serotyping of oral and sputum strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
    Komiyama K; Habbick BF; Martin T; Tumber SK
    Can J Microbiol; 1987 Mar; 33(3):221-5. PubMed ID: 3105857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial activity of tobramycin against respiratory cystic fibrosis Pseudomonas aeruginosa isolates from Bulgaria.
    Strateva T; Petrova G; Mitov I
    J Chemother; 2010 Dec; 22(6):378-83. PubMed ID: 21303744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa and Periodontal Pathogens in the Oral Cavity and Lungs of Cystic Fibrosis Patients: a Case-Control Study.
    Rivas Caldas R; Le Gall F; Revert K; Rault G; Virmaux M; Gouriou S; Héry-Arnaud G; Barbier G; Boisramé S
    J Clin Microbiol; 2015 Jun; 53(6):1898-907. PubMed ID: 25854483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotypes and antibiotic susceptibilities of Pseudomonas aeruginosa isolates from single sputa of cystic fibrosis patients.
    Seale TW; Thirkill H; Tarpay M; Flux M; Rennert OM
    J Clin Microbiol; 1979 Jan; 9(1):72-8. PubMed ID: 107186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral colonization and susceptibility testing of Pseudomonas aeruginosa oral isolates from cystic fibrosis patients.
    Lindemann RA; Newman MG; Kaufman AK; Le TV
    J Dent Res; 1985 Jan; 64(1):54-7. PubMed ID: 3918088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucoid Pseudomonas aeruginosa and cystic fibrosis: resistance of the mucoid from to carbenicillin, flucloxacillin and tobramycin and the isolation of mucoid variants in vitro.
    Govan JR; Fyfe JA
    J Antimicrob Chemother; 1978 May; 4(3):233-40. PubMed ID: 97259
    [No Abstract]   [Full Text] [Related]  

  • 8. Mucoid Pseudomonas aeruginosa and regional inflammation in the cystic fibrosis lung.
    Malhotra S; Hayes D; Wozniak DJ
    J Cyst Fibros; 2019 Nov; 18(6):796-803. PubMed ID: 31036488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections.
    Koeva M; Gutu AD; Hebert W; Wager JD; Yonker LM; O'Toole GA; Ausubel FM; Moskowitz SM; Joseph-McCarthy D
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interbacterial adhesion between Pseudomonas aeruginosa and indigenous oral bacteria isolated from patients with cystic fibrosis.
    Komiyama K; Habbick BF; Gibbons RJ
    Can J Microbiol; 1987 Jan; 33(1):27-32. PubMed ID: 3105855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity and reduction in pulmonary clearance of mucoid Pseudomonas aeruginosa.
    Govan JR; Fyfe JA; Baker NR
    Rev Infect Dis; 1983; 5 Suppl 5():S874-9. PubMed ID: 6419313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple of isolates of Pseudomonas aeruginosa with differing antimicrobial susceptibility patterns from patients with cystic fibrosis.
    Thomassen MJ; Demko CA; Boxerbaum B; Stern RC; Kuchenbrod PJ
    J Infect Dis; 1979 Dec; 140(6):873-80. PubMed ID: 120383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of antibiotic resistance in mucoid isolates of Pseudomonas aeruginosa obtained from cystic fibrosis patients: role of outer membrane proteins.
    Irvin RT; Govan JW; Fyfe JA; Costerton JW
    Antimicrob Agents Chemother; 1981 Jun; 19(6):1056-63. PubMed ID: 6791585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polysaccharide surface antigens expressed by nonmucoid isolates of Pseudomonas aeruginosa from cystic fibrosis patients.
    Pier GB; Desjardins D; Aguilar T; Barnard M; Speert DP
    J Clin Microbiol; 1986 Aug; 24(2):189-96. PubMed ID: 2943759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis.
    Henry RL; Mellis CM; Petrovic L
    Pediatr Pulmonol; 1992 Mar; 12(3):158-61. PubMed ID: 1641272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sputum from patients with cystic fibrosis on the activity in vitro of 5 antimicrobial drugs on Pseudomonas aeruginosa.
    Davis SD; Bruns WT
    Am Rev Respir Dis; 1978 Jan; 117(1):176-8. PubMed ID: 413461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis.
    Smith AL; Fiel SB; Mayer-Hamblett N; Ramsey B; Burns JL
    Chest; 2003 May; 123(5):1495-502. PubMed ID: 12740266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity of respiratory strains of Pseudomonas aeruginosa to carbenicillin.
    May JR; Ingold A
    J Med Microbiol; 1973 Feb; 6(1):77-82. PubMed ID: 4632255
    [No Abstract]   [Full Text] [Related]  

  • 19. Facilitated detection of antibiotic-resistant Pseudomonas in cystic fibrosis sputum using homogenized specimens and antibiotic-containing media.
    Maduri-Traczewski M; L'Heureux C; Escalona L; Macone A; Goldmann D
    Diagn Microbiol Infect Dis; 1986 Nov; 5(4):299-305. PubMed ID: 3096628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of human respiratory secretions by mucoid Pseudomonas aeruginosa of cystic fibrosis origin.
    Ohman DE; Chakrabarty AM
    Infect Immun; 1982 Aug; 37(2):662-9. PubMed ID: 6811437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.